450 related articles for article (PubMed ID: 25584011)
21. Structural and functional study of FK domain of Fstl1.
Li X; Li L; Chang Y; Ning W; Liu X
Protein Sci; 2019 Oct; 28(10):1819-1829. PubMed ID: 31351024
[TBL] [Abstract][Full Text] [Related]
22. FSTL1 promotes alveolar epithelial cell aging and worsens pulmonary fibrosis by affecting SENP1-mediated DeSUMOylation.
Sun W; Yang X; Chen L; Guo L; Huang H; Liu X; Yang Y; Xu Z
Cell Biol Int; 2023 Oct; 47(10):1716-1727. PubMed ID: 37369969
[TBL] [Abstract][Full Text] [Related]
23. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
24. Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice.
Kinoshita K; Aono Y; Azuma M; Kishi J; Takezaki A; Kishi M; Makino H; Okazaki H; Uehara H; Izumi K; Sone S; Nishioka Y
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):536-43. PubMed ID: 23642017
[TBL] [Abstract][Full Text] [Related]
25. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
[TBL] [Abstract][Full Text] [Related]
27. Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice.
Tanaka K; Tanaka Y; Namba T; Azuma A; Mizushima T
Biochem Pharmacol; 2010 Sep; 80(6):920-31. PubMed ID: 20513440
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic effects of evasin-1, a chemokine binding protein, in bleomycin-induced pulmonary fibrosis.
Russo RC; Alessandri AL; Garcia CC; Cordeiro BF; Pinho V; Cassali GD; Proudfoot AE; Teixeira MM
Am J Respir Cell Mol Biol; 2011 Jul; 45(1):72-80. PubMed ID: 20833968
[TBL] [Abstract][Full Text] [Related]
29. Fstl1 Promotes Glioma Growth Through the BMP4/Smad1/5/8 Signaling Pathway.
Jin X; Nie E; Zhou X; Zeng A; Yu T; Zhi T; Jiang K; Wang Y; Zhang J; You Y
Cell Physiol Biochem; 2017; 44(4):1616-1628. PubMed ID: 29212066
[TBL] [Abstract][Full Text] [Related]
30. Apical Secretion of FSTL1 in the Respiratory Epithelium for Normal Lung Development.
Li X; Fang Y; Li X; Liang J; Jiang D; Geng Y; Ning W
PLoS One; 2016; 11(6):e0158385. PubMed ID: 27355685
[TBL] [Abstract][Full Text] [Related]
31. Latent transforming growth factor-β1 protects against bleomycin-induced lung injury in mice.
Tang YJ; Xiao J; Huang XR; Zhang Y; Yang C; Meng XM; Feng YL; Wang XJ; Hui DS; Yu CM; Lan HY
Am J Respir Cell Mol Biol; 2014 Dec; 51(6):761-71. PubMed ID: 24885478
[TBL] [Abstract][Full Text] [Related]
32. Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture.
Maruyama S; Nakamura K; Papanicolaou KN; Sano S; Shimizu I; Asaumi Y; van den Hoff MJ; Ouchi N; Recchia FA; Walsh K
EMBO Mol Med; 2016 Aug; 8(8):949-66. PubMed ID: 27234440
[TBL] [Abstract][Full Text] [Related]
33. Follistatin-like protein 1 regulates chondrocyte proliferation and chondrogenic differentiation of mesenchymal stem cells.
Chaly Y; Blair HC; Smith SM; Bushnell DS; Marinov AD; Campfield BT; Hirsch R
Ann Rheum Dis; 2015 Jul; 74(7):1467-73. PubMed ID: 24641944
[TBL] [Abstract][Full Text] [Related]
34. Ameliorative effect of mepenzolate bromide against pulmonary fibrosis.
Kurotsu S; Tanaka K; Niino T; Asano T; Sugizaki T; Azuma A; Suzuki H; Mizushima T
J Pharmacol Exp Ther; 2014 Jul; 350(1):79-88. PubMed ID: 24769542
[TBL] [Abstract][Full Text] [Related]
35. Pathogenesis pathways of idiopathic pulmonary fibrosis in bleomycin-induced lung injury model in mice.
Shi K; Jiang J; Ma T; Xie J; Duan L; Chen R; Song P; Yu Z; Liu C; Zhu Q; Zheng J
Respir Physiol Neurobiol; 2014 Jan; 190():113-7. PubMed ID: 24140943
[TBL] [Abstract][Full Text] [Related]
36. Receptor-activated Smad localisation in bleomycin-induced pulmonary fibrosis.
Higashiyama H; Yoshimoto D; Okamoto Y; Kikkawa H; Asano S; Kinoshita M
J Clin Pathol; 2007 Mar; 60(3):283-9. PubMed ID: 16751304
[TBL] [Abstract][Full Text] [Related]
37. Focal Adhesion Kinase Regulates Fibroblast Migration via Integrin beta-1 and Plays a Central Role in Fibrosis.
Zhao XK; Cheng Y; Liang Cheng M; Yu L; Mu M; Li H; Liu Y; Zhang B; Yao Y; Guo H; Wang R; Zhang Q
Sci Rep; 2016 Jan; 6():19276. PubMed ID: 26763945
[TBL] [Abstract][Full Text] [Related]
38. C/EBPβ-Thr217 phosphorylation signaling contributes to the development of lung injury and fibrosis in mice.
Buck M; Chojkier M
PLoS One; 2011; 6(10):e25497. PubMed ID: 21998664
[TBL] [Abstract][Full Text] [Related]
39. Asiaticoside attenuates bleomycin-induced pulmonary fibrosis in A2aR
Zhang T; Dai J; Ye W; Cai L; Wei J; Chen M; Huang X; Wang X
Biochem Biophys Res Commun; 2020 Jun; 527(3):662-667. PubMed ID: 32423816
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis.
Aguilar S; Scotton CJ; McNulty K; Nye E; Stamp G; Laurent G; Bonnet D; Janes SM
PLoS One; 2009 Nov; 4(11):e8013. PubMed ID: 19956603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
